{"name":"Five Eleven Pharma, Inc.","slug":"five-eleven-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"[18F]P17-059","genericName":"[18F]P17-059","slug":"18f-p17-059","indication":"Other","status":"phase_1"},{"name":"[18F]P16-129","genericName":"[18F]P16-129","slug":"18f-p16-129","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"[18F]P17-059","genericName":"[18F]P17-059","slug":"18f-p17-059","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"[18F]P16-129","genericName":"[18F]P16-129","slug":"18f-p16-129","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE5IOW1aSWhJWTdKdkZRMzBSd09mbWlUWHNMY2VzRDJSX0c0RmdMSFFXSGJOS3VrS3E4NHItdVIwcHVxQXNRUVFleGM2Sm5RTDhL?oc=5","date":"2026-04-07","type":"pipeline","source":"The Edge Malaysia","summary":"Pharmaniaga plans five-to-one share consolidation - The Edge Malaysia","headline":"Pharmaniaga plans five-to-one share consolidation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNdFNMWFhBZnhwZEFLbV9NeU9YcWlIazZIN1l2cHB1dkM4dnBHM0dpWG9hRG5sY3BBc2QzT2lyT1ZYTzh6b05leXFBZU0zam9PQnQ5b2VCNkFOcjlZX3cza19hRlpSWUJDZE4yeTBaWEhJRWFXR0F5S2t2S2FZaDgwNmJKdXNjRS1ac1Mwak1HZTJZVjVoZGhVM3IyODFSZ3FYLXJKWHhCSQ?oc=5","date":"2026-02-11","type":"pipeline","source":"Medical Marketing and Media","summary":"Five things for pharma marketers to know for Wednesday, February 11, 2026 - Medical Marketing and Media","headline":"Five things for pharma marketers to know for Wednesday, February 11, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1XNUt5ZUt0dDM3NlVtZ1lTWEllbDgyVEVhZVBjTXozY2loLURNTkpqaC1PU1JCd19KRGVKZUhheExxQXZjSFE3bGdHc3lYRTh1aDFv?oc=5","date":"2026-01-22","type":"pipeline","source":"FirstWord Pharma","summary":"Friday Five – Sayonara, Stelara woes?, GSK 'RAPT' with allergy bet, Novo's oral redemption…and more - FirstWord Pharma","headline":"Friday Five – Sayonara, Stelara woes?, GSK 'RAPT' with allergy bet, Novo's oral redemption…and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPcUYxVmJxX3RudVVGNkxvdm1JOHJRTWFQWGJtMzJqcmZPSnlOSWVGZTFhVlVHNHNNdUZPWG5FY2J6dVhWOFVYVFkxQW1iUkFKY3l2UmctUk53anFsUjJ1VUd4WVY4UUNkTXJxd1RQZFZhYUE0ZnJray1xcXJBTUg1SzVOemxoanEtVllsMVM0aGNFOGZaNlk1Q0E2ZWZrSXZIbHktM0I4V3ZyMnEt?oc=5","date":"2025-12-11","type":"pipeline","source":"businesswire.com","summary":"Termination of Proposed Acquisition of Mayne Pharma - businesswire.com","headline":"Termination of Proposed Acquisition of Mayne Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOcThKXzc4aHZTNlNudnE4OUt5UUl5bWUzSkdFTW9tbTR4QmU5MDl2YmZWR1FQRGxBeEVBUGE0dXR1dUxSYmk5LWhNZXhMMkRaaEl6TDVob09FUVVzQkRjcUdfNkxoOEotTndLR0tBMmhvbVhURVhocUN5TGxiVDJWQmktaFdYbDZXcjMxR1JOMXg?oc=5","date":"2025-12-06","type":"trial","source":"The Pharma Letter","summary":"Vertex presents new data on Casgevy at ASH - The Pharma Letter","headline":"Vertex presents new data on Casgevy at ASH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOYzM5aGNOa25kc2d0cWtzZ21CMnNsOUc4U3h0cDVwcGpjOUtyMWplNHZieGxYd3FLZlV1MW5OaUVWWUNoZW1fd2swc3A1UE11dENiQlNYMThqRDk5eEF1aXpPd2VNZy00bG83MUpLT1RqQlktN2FEWFVuRWJxaUk3Yk4zUE8tSXM2Z2dqOEc1SDBWT0ZVNWs4Z1pwT2poLU1Wclk5YUxMMlJtckk4dzdMMS04SVAyR29QLVNKZnpZdEtrd3do?oc=5","date":"2025-11-18","type":"regulatory","source":"Live 5 News","summary":"Judge approves $7B opioid settlement for Purdue Pharma and Sackler family members who own the company - Live 5 News","headline":"Judge approves $7B opioid settlement for Purdue Pharma and Sackler family members who own the company - Live 5 News","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOa3JsNENYOTNfU1pzSzMxdEFNNTBhNzhPd3RYN3EtLWxDOFFiZFBOMWlNMVpCaFV2UVRIWkR3UThWMjNlX1dsMUFWQmZfTFJpdUNRR1ZheXBjODl2RUU2OFhneFMzbl9rVVgzaEJzaDlDdTNwMkZhMXdkRlQwMmh1SzV5eERYckNCLWFqRjkxbmpTX05jcGNMenBpNFYxNm1LNjJWcFgxS21aVjBZdUUyNg?oc=5","date":"2025-11-12","type":"pipeline","source":"BioSpace","summary":"Five Trends That Got Everyone Talking in Pharma and Biotech This Year - BioSpace","headline":"Five Trends That Got Everyone Talking in Pharma and Biotech This Year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQWVNLQl9FR1pzNHc2X1RZZ0dEUUR4Q3VZc1FCVl9ia2Z5bzR3Vnh3a0R5UEloNGZtM25EYVlmN1J3ZDRGc3R1bXFnWEptZ2tHZ0xVekFBaE0wYmczTEo5OTJYdnJVdWU3SDdZN1RNZ1M1YTlTY0RkbkhkMmN6SWxmdURaNE43LXlXN1E?oc=5","date":"2025-11-11","type":"pipeline","source":"Medical Marketing and Media","summary":"Five things for pharma marketers to know for Tuesday, November 11, 2025 - Medical Marketing and Media","headline":"Five things for pharma marketers to know for Tuesday, November 11, 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPVDNQVmdpVFo5SzRJZjBobkE5aXhkMWFWUzF0Nmo5UFRjSWNkQkpWRlg5czVqdlpsNUhUWk5qOEJoOUxwZmZ4WmRjaFVXdlVxM0RzVmxQN0lSaXJhYXlEUUlBUTA1ZXZ0UVU1ZXFCV0RIa1RDOUNIYmh0UV9KejN4M3luaVphWXF6R2xqNU1TX0Zvem1nbEVHTmpWcVNXMkE?oc=5","date":"2025-09-11","type":"pipeline","source":"Fierce Pharma","summary":"Amid restructuring, Novo Nordisk directs employees to return to office - Fierce Pharma","headline":"Amid restructuring, Novo Nordisk directs employees to return to office","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNUFN4Nl96bVBMU2JsWjJucWVCQXI0elA5UEF1RTFYSGUydlJXenNyT2ZyNVhfeTBTcFUtTTd6RGFmSjFVMkdVOVZFd21aT29QMEYzbDF3NDh5Wk9tTkxJRTJiVWJIT2kyRXo2ZmFXM0cwSGxwUFowV1lVQ2tOQU1OY2tfMngwTmNZSEVqRkxOSElJZ3fSAZgBQVVfeXFMT0RpNW5WVEo4bHZ3NDlrbWFDVG9GYUwtN2xsWUNNbzU2TFAwVXVqN1BPQkhDTHlZbENMNzJxb0RvVzUtcDZqTW5xQ0pWM21wRDQ0bzlTZmpLNURSQ3V3dDBRZ2dLckJJaEJmWm96UnpEbXlOeXNSbVJCV1o5ckt4WVVlWmVlNms5dE8yZFFfdVZQd1BjSkNmS2E?oc=5","date":"2025-06-19","type":"pipeline","source":"Forbes India","summary":"Top 10 pharma companies in India by market cap [2025] - Forbes India","headline":"Top 10 pharma companies in India by market cap [2025]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQd1IxT0FqMjF3QndPNG52T2swRXBvTmpmWmdfTG4xdVh6dHZOQ1JnM01rN0syc2xneXA5Qm95b1czbEdRSl91eV9ERTNZTE96T01rMmdqaGZJdDNPbGczeHBCamFmXzNzUm1QM1BoQUhoSzQ3T1dZZGg3QUY4cWVScFZjeERZeXhFRlpyYWZ0MGFaS3NGS2NhRElMaEJBSDBVMWVoS0s4b1FQVE9EdGFnb2Z3OC1wVFRmMXdsSWF2azJZYndLUkRaLTF1QQ?oc=5","date":"2023-10-11","type":"pipeline","source":"McKinsey & Company","summary":"A vision for medical affairs 2030: Five priorities for patient impact - McKinsey & Company","headline":"A vision for medical affairs 2030: Five priorities for patient impact - McKinsey & Company","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}